## **Core Concept**
Leiomyosarcoma is a type of malignant smooth muscle tumor. Chemotherapeutic agents are used to treat various cancers, including leiomyosarcoma. The effectiveness of these agents varies depending on the specific type of cancer.

## **Why the Correct Answer is Right**
Gemcitabine and Docetaxel have shown efficacy in treating leiomyosarcoma. However, among the given options, **Gemcitabine** is recognized for its activity against leiomyosarcoma, particularly when used in combination with other agents like Docetaxel. It works by inhibiting DNA synthesis, thereby preventing cell division.

## **Why Each Wrong Option is Incorrect**
* **Option A:** Doxorubicin is a chemotherapeutic agent used in various cancers but is not the most active single agent specifically for leiomyosarcoma compared to others listed.
* **Option B:** Ifosfamide is another chemotherapeutic agent with a broad spectrum of activity but is not highlighted as the most effective single agent for leiomyosarcoma.
* **Option D:** Etoposide is used in treating certain types of cancer, including some sarcomas, but it is not noted for being the most active single agent in leiomyosarcoma.

## **Clinical Pearl / High-Yield Fact**
A notable clinical pearl is that the combination of Gemcitabine and Docetaxel has been specifically highlighted in the treatment of leiomyosarcoma, showing significant activity. This combination is an example of how chemotherapy can be tailored to specific tumor types for better outcomes.

## **Correct Answer:** .